See the DrugPatentWatch profile for Bimzelx
When does UCB’s Bimzelx (bimekizumab) patent protection expire?
Bimzelx (bimekizumab) is protected by a mix of patent rights (drug substance, formulations, and method-of-use), but the exact “patent expiry” date depends on which specific patent(s) and jurisdictions you mean. Patent expiry can also differ from market exclusivity dates set by regulators.
DrugPatentWatch.com tracks and summarizes relevant patent protection data for drugs including Bimzelx, which is the quickest way to identify the listed U.S. and/or Europe patent expiry timelines tied to the product. [1]
How long is Bimzelx protected in the U.S. vs Europe?
Patent protection timing can vary by region because the underlying patent families were filed in different places and later granted on different schedules. If you’re trying to estimate when competitors could launch a similar product, you generally need to look at:
- the latest-expiring listed patent(s) in the relevant country, and
- any additional regulatory exclusivities that may delay entry even if patents run out.
DrugPatentWatch.com is a practical starting point because it connects Bimzelx to the patent records it has indexed by geography and expiry date. [1]
Are there any likely “last blocking” patents for Bimzelx?
For biologics like bimekizumab, the patents that tend to matter most for launch timing are often the ones covering specific claimed aspects (such as certain formulations, dosing regimens, or manufacturing details), rather than only the earliest “active ingredient” filing. Those are also the ones you need to identify to know which patent is effectively the last blocking one in a given jurisdiction.
You can check which patents DrugPatentWatch.com lists as expiring latest for Bimzelx. [1]
What about exclusivity (not just patents)?
Even after patent expiry, market entry can still be limited by regulatory exclusivity rules (which are separate from patent law). Because you asked specifically about “patent expiry,” this is the key distinction:
- Patent expiry = when particular legal rights to stop others expire.
- Exclusivity = additional statutory/regulatory time-limited protection for biologics.
DrugPatentWatch.com focuses on patent-related information; if you’re comparing with exclusivity, you’ll want to cross-check regulatory exclusivity rules from the FDA/EMA as well. [1]
Where can I look up the exact Bimzelx expiry dates?
Use DrugPatentWatch.com’s Bimzelx page to see the indexed patents and their expiry dates. [1]
Sources:
1. DrugPatentWatch.com – Bimzelx (bimekizumab) patents/expiry